ğğšğ¬ğžğ¥ğ¢ğ§ğž 𝐒𝐭𝐮𝐝𝐲
We are doing 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗢𝗣𝗘𝗡 𝗖𝗢𝗛𝗢𝗥𝗧 𝗦𝗧𝗨𝗗𝗬 (𝗖𝗢𝗖𝗦) to provide better understanding of definitions, clinical picture, determinants and distribution of coronavirus pandemic (Covid-19) across various populations and geographical locations globally.

This study has the required approvals disclosed in the preliminary sections on the survey. It is estimated that the survey will take an average of 10 minutes to complete.

Participation in this study is completely voluntary and your responses will be strictly confidential. Data from this research will be reported only in the aggregate. Your information will remain confidential.

Thank you. We really appreciate your time and effort.

ğğ¥ğžğšğ¬ğž 𝐮𝐬𝐞 ğ†ğ¨ğ¨ğ ğ¥ğž ğ‚ğ¡ğ«ğ¨ğ¦ğž 𝐚𝐬 𝐲𝐨𝐮𝐫 ğ›ğ«ğ¨ğ°ğ¬ğžğ« 𝐰𝐡𝐞𝐧 ğœğ¨ğ¦ğ©ğ¥ğžğ­ğ¢ğ§ğ  𝐭𝐡𝐢𝐬 𝐬𝐮𝐫𝐯𝐞𝐲.

ğ‘ğžğ¦ğžğ¦ğ›ğžğ« 𝐭𝐨 𝐜𝐥𝐢𝐜𝐤 𝐧𝐞𝐱𝐭 𝐰𝐡𝐞𝐧 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐝 𝐚𝐧𝐝 𝐒𝐮𝐛𝐦𝐢𝐭 𝐰𝐡𝐞𝐧 𝐲𝐨𝐮 ğ¡ğšğ¯ğž ğœğ¨ğ¦ğ©ğ¥ğžğ­ğžğ!
𝐖𝐡𝐢𝐜𝐡 ğšğ ğž 𝐠𝐫𝐨𝐮𝐩 𝐝𝐨 𝐲𝐨𝐮 𝐟𝐚𝐥𝐥 𝐮𝐧𝐝𝐞𝐫 (𝐢𝐧 ğ²ğžğšğ«ğ¬)? *
ğ‚ğŽğ•ğˆğƒ-𝟏𝟗 𝐨𝐩𝐞𝐧 𝐜𝐨𝐡𝐨𝐫𝐭 𝐬𝐭𝐮𝐝𝐲 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥-𝐔𝐍𝐂𝐒𝐓
ğ‚ğŽğ•ğˆğƒ-𝟏𝟗 𝐨𝐩𝐞𝐧 𝐜𝐨𝐡𝐨𝐫𝐭 𝐬𝐭𝐮𝐝𝐲 𝐑𝐄𝐂 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 ğ§ğ¨ğ­ğ¢ğœğž
ğ‚ğŽğ•ğˆğƒ-𝟏𝟗 𝐨𝐩𝐞𝐧 𝐜𝐨𝐡𝐨𝐫𝐭 𝐬𝐭𝐮𝐝𝐲 ğ¢ğ§ğŸğ¨ğ«ğ¦ğžğ ğœğ¨ğ§ğ¬ğžğ§ğ­
𝐀: 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧
COVID-19 is a virus strain, first identified in Wuhan, Hubei Province, China, that has only spread in people since December 2019 and has now become a world pandemic.

The symptoms of COVID-19 are non-specific, but commonly presents with fever, tiredness, and dry cough. Some patients may have difficult breathing, aches and pains, nasal congestion, runny nose, sore throat or diarrhoea. These symptoms are usually mild and begin gradually. People with fever, cough and difficulty breathing should seek medical attention. No effective treatment has been recommended yet with patients provided with supportive care. However, there are several ongoing clinical trials that include both western and traditional medicines.

The disease spreads from an infected person to others through breathing in droplets from the nose or mouth during coughing or sneezing. Droplet contaminated surfaces including human body parts may also spread the disease when a person touches such surfaces and then touch their eyes, nose or mouth.

𝐁: 𝐒𝐭𝐮𝐝𝐲 𝐩𝐮𝐫𝐩𝐨𝐬𝐞: What is the reason for doing this study?
This study will contribute to the refinement of case definitions and advance epidemiology of COVID-19. It will provide opportunity to validate the WHO criteria across different populations, status of pandemic and locations. This information will inform further research and public health messages and interventions.

𝐂: 𝐒𝐭𝐮𝐝𝐲 ğğ«ğ¨ğœğžğğ®ğ«ğžğ¬: What will this study involve?
We would like to study the epidemiology of COVID-19 using an online Open Cohort approach on 5,000 respondents globally using an initial baseline data collection tool filled in once and then very short fortnightly questions filled. The form will be circulated through emails and available social media globally. It will also be available for download on the study website.

𝐃: 𝐑𝐢𝐬𝐤𝐬 𝐚𝐧𝐝 ğğžğ§ğžğŸğ¢ğ­ğ¬ 𝐨𝐟 𝐬𝐭𝐮𝐝𝐲 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧
The study poses no more than minimal risks to the participants.There are also no direct benefits from this study but by taking part you may help us improve the case definitions and epidemiology of COVID-19.

𝐄: ğ‚ğ¨ğ¦ğ©ğžğ§ğ¬ğšğ­ğ¢ğ¨ğ§
It will not cost you any money to take part in this study neither you will not be paid for participation.

𝐅: ğ‚ğ¨ğ§ğŸğ¢ğğžğ§ğ­ğ¢ğšğ¥ğ¢ğ­ğ²: Who will have access to information about me in this research?
All data is anonymised and stored in password protected computers. No unauthorised personnel will be allowed to view your data apart from the study team and regulatory authorities.

𝐆: 𝐒𝐭𝐮𝐝𝐲 ğ«ğžğ ğ®ğ¥ğšğ­ğ¢ğ¨ğ§: Who has allowed this research to take place?
This research study has been approved by the Mbale Regional Referral Hospital Research and Ethics Committee (MRRH-REC) and the Uganda National Council of Science and Technology (UNCST).

𝐇: ğ…ğ®ğ«ğ­ğ¡ğžğ« 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬: What if I have any questions?
You may ask questions at any time during the study through contacting the principal investigator of the study:
Professor Peter Olupot-Olupot; MBCHB, MPH, PHD, FUNAS; Mbale Clinical Research Institute, P.O Box 1966, Mbale. polupotolupot@yahoo.com; Mobile: + 256 (0)772-457-217/ Tel: (0)392910171/ (0)352280584/ (0)45 4433193 Fax: +256 45 4435894

If you want to ask someone independent about this research please contact:
The Mbale Regional Referral Hospital Research & Ethics Committee (MRRH-REC), Mr. Francis Okello, P.O. Box 921, Mbale, Uganda. Telephone +256 (0)7820-733-475, mrrhrec@gmail.com .
ğ‚ğŽğ•ğˆğƒ-𝟏𝟗 𝐨𝐩𝐞𝐧 𝐜𝐨𝐡𝐨𝐫𝐭 𝐬𝐭𝐮𝐝𝐲 𝐨𝐧𝐥𝐢𝐧𝐞 ğœğ¨ğ§ğ¬ğžğ§ğ­? Please select your choice below. *
Yes
No
I confirm that I have read and understood the consent for the COCS Study
I understand that my participation is voluntary
I understand the aspects of confidentiality being exhibited in this study
I understand that there is no financial reimbursement for participation in this study.
I certify that I am 18 years old or older
𝐁𝐲 ğšğ ğ«ğžğžğ¢ğ§ğ  𝐭𝐨 ğ©ğšğ«ğ­ğ¢ğœğ¢ğ©ğšğ­ğž 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐨𝐧𝐥𝐢𝐧𝐞 𝐬𝐭𝐮𝐝𝐲, 𝐦𝐲 𝐞𝐧𝐝𝐨𝐫𝐬𝐞𝐦𝐞𝐧𝐭 𝐢𝐬 ğžğªğ®ğ¢ğ¯ğšğ¥ğžğ§ğ­ 𝐭𝐨 𝐦𝐲 𝐰𝐞𝐭 ğ¬ğ¢ğ ğ§ğšğ­ğ®ğ«ğž 𝐨𝐫 𝐭𝐡𝐮𝐦𝐛 𝐩𝐫𝐢𝐧𝐭 (𝑨𝒈𝒆 𝒐𝒇 𝒄𝒐𝒏𝒔𝒆𝒏𝒕 𝒊𝒔 18 𝒚𝒆𝒂𝒓𝒔 𝒂𝒏𝒅 𝒂𝒃𝒐𝒗𝒆). *
Next
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy